The Investment Column: New cancer drug is a mixed blessing for Oxford


Oxford Biomedica

Our view: Cautious hold

Share price: 25.75p (-2.25p)

While it might not have exactly all its eggs in one basket, the biopharmaceutical group Oxford Biomedica is lauding one particular venture to support its credentials, developing the drug Trovax.

Trovax, a treatment that will hopefully combat all solid tumours, has just entered the third and final stage of its kidney cancer trial and is already fully subscribed with patients ready to try it. If it works, it will be doubtlessly be good news for cancer suffers, but for investors the picture is a little more blurred.

Some are more than a little dubious about whether the group is a solid investment choice, largely because of what they describe as an all-too-narrow second phase of Trovax's trial. According to analysts at Investec, most second phase trials would normally include a survival study – how many people actually benefit from the new treatment – but that this will only be considered in the third and final phase of the Trovax tests. Given that it will take until next year to generate any meaningful results, selling Oxford Biomedica stock is the way forward, they say.

The company's chief executive, Alan Kingsman, as well as other analysts, rubbish this suggestion arguing that few second-phase trials have a survival study and that it would have been prohibitively expensive at around £15m to include.

He argues that the drug has the potential to be a revolutionary cancer treatment and the speed with which the company has recruited patients for phase three shows that practising clinicians are enthusiastic about the drug's chances of success. Furthermore, he points to the fact that pharmaceutical giant Sanofi-Aventis has invested in the drug by entering into a licensing agreement with Oxford Biomedica, worth as much as €518m (£395m). Sceptical analysts point out that much of the money will only be paid on the successful completion of the trial.

The company does have other projects: ProSavin to treat Parkinson's and Hi8 to tackle skin cancer.

The results are encouraging say analysts with net losses narrowing to £15.3m from £17.7m last year. Cautious hold.

Brixton

Our view: Buy

Share price: 320p (+10p)

"These results are to sit up and take notice of," say analysts at Lehman Brothers of Brixton's latest numbers published yesterday.

While most in the commercial property sector found 2007 heavy going, Brixton's figures posted yesterday beat expectations and led most analysts to recommend a buy, albeit a cautious one. Net asset value, which measures the value of asset against the value of liabilities, was at 545p, comfortably beating analysts' consensus of 524p.

The main feather in Brixton's 19 million square feet cap is the property it holds in west London, especially around Heathrow airport. In total, 77 per cent of its holdings are in London, were the downturn has been felt less than in other parts of the country – a view supported by Brixton's rental growth of 5 per cent in the past year, versus about 1 per cent across the rest of the sector.

According to Lehman Brothers, "the management has simply read the situation better than most of its competitors and positioned the business more effectively". This point is taken up by others; Citigroup believes that, "management has a track record of generating rental growth well above the average from its portfolio which, at a time when further yield compression is unlikely, should spur values".

All this does not mean the group is immune from the market. Further upset in the real estate market can only be bad for the group and the company's shares fell by 49 per cent in 2007, underperforming the sector by 17 per cent. On the other hand, so far this year shares are up 8.5 per cent. Buy.

Irish Continental

Our view: Hold

Share price: €24.90 (+ 17 cents)

This is likely to be a challenging year for Irish Continental. The company posted what were described by Merrion Landsbanki analysts as, "excellent" results yesterday with profits rising to €50.1m from €32.2m in 2006, but this year is set to be tougher. By the group's own admission, the surge in the price of oil, up 71 per cent in the past year, is likely to have a detrimental effect on the business, which relies heavily on car passengers. The company has seen car volumes drop by 11 per cent this year.

Moreover, the group is likely to suffer from fewer tourists visiting Ireland from the UK due to economic woes. Yet another problem facing the group is the falling rate of sterling versus the euro, a bad thing says the company.

But investors can take heart from a few things. The company is about 70 per cent owned by just three shareholders – groups known as Aella, Moonduster and the property developer Liam Carroll – all of which have expressed an interest in buying the group. This might not lead to great upside, according to Merrion Landsbanki, but it has kept the share price pretty stable. Hold.

Life and Style
Social media users in Mexico who commented on cartel violence have been killed in the past
techTweets not showing up or loading this morning, users say
Sport
premier leagueLive: All the latest news and scores from today's matches
News
newsMcKamey Manor says 'there is no escape until the tour is completed'
News
politics
PROMOTED VIDEO
News
ebooksAn unforgettable anthology of contemporary reportage
Sport
Fans of Dulwich Hamlet FC at their ground Champion Hill
footballFans are rejecting the £2,000 season tickets, officious stewarding, and airline-stadium sponsorship
News
Shami Chakrabarti
people
Arts and Entertainment
Benedict Cumberbatch has refused to deny his involvement in the upcoming new Star Wars film
filmBenedict Cumberbatch reignites Star Wars 7 rumours
Sport
football
News
news
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Compensation and Benefits Manager - Brentwood - Circa £60,000

£60000 per annum: Ashdown Group: Compensation and Benefits Manager - Compensat...

Data Analyst/Planning and Performance – Surrey – Up to £35k

£30000 - £35000 Per Annum plus excellent benefits: Clearwater People Solutions...

IT Systems Business Analyst - Watford - £28k + bonus + benefits

£24000 - £28000 per annum + bonus & benefits: Ashdown Group: IT Business Syste...

Markit EDM (CADIS) Developer

£50000 - £90000 per annum + benefits: Ampersand Consulting LLP: Markit EDM (CA...

Day In a Page

Wilko Johnson, now the bad news: musician splits with manager after police investigate assault claims

Wilko Johnson, now the bad news

Former Dr Feelgood splits with manager after police investigate assault claims
Mark Udall: The Democrat Senator with a fight on his hands ahead of the US midterm elections

Mark Udall: The Democrat Senator with a fight on his hands

The Senator for Colorado is for gay rights, for abortion rights – and in the Republicans’ sights as they threaten to take control of the Senate next month
New discoveries show more contact between far-flung prehistoric humans than had been thought

New discoveries show more contact between far-flung prehistoric humans than had been thought

Evidence found of contact between Easter Islanders and South America
Cerys Matthews reveals how her uncle taped 150 interviews for a biography of Dylan Thomas

Cerys Matthews on Dylan Thomas

The singer reveals how her uncle taped 150 interviews for a biography of the famous Welsh poet
DIY is not fun and we've finally realised this as a nation

Homebase closures: 'DIY is not fun'

Homebase has announced the closure of one in four of its stores. Nick Harding, who never did know his awl from his elbow, is glad to see the back of DIY
The Battle of the Five Armies: Air New Zealand releases new Hobbit-inspired in-flight video

Air New Zealand's wizard in-flight video

The airline has released a new Hobbit-inspired clip dubbed "The most epic safety video ever made"
Pumpkin spice is the flavour of the month - but can you stomach the sweetness?

Pumpkin spice is the flavour of the month

The combination of cinnamon, clove, nutmeg (and no actual pumpkin), now flavours everything from lattes to cream cheese in the US
11 best sonic skincare brushes

11 best sonic skincare brushes

Forget the flannel - take skincare to the next level by using your favourite cleanser with a sonic facial brush
Paul Scholes column: I'm not worried about Manchester United's defence - Chelsea test can be the making of Phil Jones and Marcos Rojo

Paul Scholes column

I'm not worried about Manchester United's defence - Chelsea test can be the making of Jones and Rojo
Frank Warren: Boxing has its problems but in all my time I've never seen a crooked fight

Frank Warren: Boxing has its problems but in all my time I've never seen a crooked fight

While other sports are stalked by corruption, we are an easy target for the critics
Jamie Roberts exclusive interview: 'I'm a man of my word – I'll stay in Paris'

Jamie Roberts: 'I'm a man of my word – I'll stay in Paris'

Wales centre says he’s not coming home but is looking to establish himself at Racing Métro
How could three tourists have been battered within an inch of their lives by a burglar in a plush London hotel?

A crime that reveals London's dark heart

How could three tourists have been battered within an inch of their lives by a burglar in a plush London hotel?
Meet 'Porridge' and 'Vampire': Chinese state TV is offering advice for citizens picking a Western moniker

Lost in translation: Western monikers

Chinese state TV is offering advice for citizens picking a Western moniker. Simon Usborne, who met a 'Porridge' and a 'Vampire' while in China, can see the problem
Handy hacks that make life easier: New book reveals how to rid your inbox of spam, protect your passwords and amplify your iPhone

Handy hacks that make life easier

New book reveals how to rid your email inbox of spam, protect your passwords and amplify your iPhone with a loo-roll
KidZania lets children try their hands at being a firefighter, doctor or factory worker for the day

KidZania: It's a small world

The new 'educational entertainment experience' in London's Shepherd's Bush will allow children to try out the jobs that are usually undertaken by adults, including firefighter, doctor or factory worker